In a systematic review and meta-analysis of available data, lotilaner ophthalmic solutions outperformed placebo, with few side effects, in treating Demodex blepharitis.
A review of insurance policies for Demodex blepharitis treatments, along with an analysis of the potential toxicities associated with these treatments.